Yang Ming Transport Corp. said the Red Sea crisis and emerging Asian markets helped profit soar by nearly $2 billion in 2024.

While policy uncertainty remains a risk, maintaining a well-diversified portfolio is essential for long-term investment ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

In 2023, global cannabis sales were estimated at $32 billion, with North America dominating over 75% of total revenue due to ...

Britain's public finances, strained by growing debt and sluggish growth, face a crucial test this month that investors say ...

The recently concluded two sessions have set a vibrant tone of optimism. Under the decisive leadership of President Xi ...

U.S. equity markets are facing severe headwinds in early 2025, while Chinese equities rally, leaving global investors – ...

Investors have their eyes on several emerging cryptocurrencies for 2025, including Dawgz AI ($DAGZ), which combines AI and ...

The stock gauge has tumbled more than 16 per cent in 2025, making it the world’s worst performer among 92 indexes tracked by ...

They say that EM will benefit as the U.S. growth scare pushes bond yields lower, encourages the Federal Reserve to cut interest rates - and unlike the historical behavior, where the dollar tended to ...

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Once considered a niche domain reserved for institutional giants and venture capital elites, private markets are undergoing a ...